What are the ingredient drugs in Technivie?
The ingredient drugs in Technivie are ombitasvir, paritaprevir, and ritonavir which are are antiviral medicines that prevent the hepatitis C virus (HCV) from multiplying in your body.
Technivie has been discontinued.
What is Technivie?
Technivie (ombitasvir, paritaprevir and ritonavir) is an NS5A inhibitor, NS3/4A protease inhibitor, and CYP3A inhibitor fixed-dose combination indicated for use in combination with ribavirin for the treatment of patients with genotype 4 chronic hepatitis C virus (HCV) infection.
Technivie can be used to treat genotype 4 HCV infections without requiring the need for interferon.
In May 2018, the FDA announced that Technivie was to be discontinued. The discontinuation was voluntary and not related to the safety, quality, or efficacy of the medicine. Supplies of Technivie were estimated to be available until January 1, 2019.